When investing in the stock market, a history of strong returns should be high on your priority list. Combine this with a positive outlook on the future, and you may have a winner to add to your portfolio.
Amgen Inc., an American multinational biopharmaceutical company, fits this mold. The company has a 10-year annualized total return of 13.69% through the end of 2022. And if that's not enough to pique your interest, consider this: It pays out billions of dollars in dividends to investors every year.
Don’t Miss:
- It's only a matter of time before Autonomous Security Robots (ASRs) are on patrol near you. This industry-leading company is offering up to $10M of bonds with 10% annual interest paid in cash.
- The VC firm that backed Apple before its IPO in 1980 is focusing on AI — Here's how you can do the same with $1,000.
The most recent Amgen stock split occurred on Nov. 22, 1999. The next day, the stock traded at $34.72. So, $1,000 would have purchased you 28.8 shares. While that may not sound like a lot of shares, time is powerful.
Today, with Amgen trading at $263.19, 28.8 shares would be worth $7,579.87. In other words, gains of $6,579.87 for doing nothing more than making a well-informed initial investment and holding onto it.
That is impressive, but don't forget that Amgen has a long history of paying dividends to its shareholders. For example, in 2023, shareholders received four equal dividend payments of $2.13 for an annualized dividend of $8.52. With only 28 shares (that's if you haven't reinvested dividends over the past 24 years), you'd earn $238.56 in dividends this year.
To top it off, Amgen has increased its annualized dividend for 11 consecutive years.
Amgen may not get as much attention as other top stock performers, such as those in the tech sector, but the company continues to provide its investors with strong growth both in its share price and dividend payouts.
Read Next:
- With returns as high as 300%, it’s no wonder this asset is the investment choice of many billionaires. Uncover the secret.
- Join the ranks of investors like Bill Gates and Mark Cuban by tapping into early-stage startups. Get the inside scoop on this innovative startup here.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.